Pre-Analytical Conditions in Non-Invasive Prenatal Testing of Cell-Free Fetal RHD

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Clausen, Frederik Banch ^a   Jakobsen, Tanja Roien ^a   Rieneck, Klaus ^a   Krog, Grethe Risum ^a   Nielsen, Leif Kofoed ^a   Tabor, Ann ^a,b   Dziegiel, Morten Hanefeld ^a,b  

^a University of Copenhagen   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

RHESUS D ANTIBODY;

ANTIBODY DETECTION; ARTICLE; BLOOD SAMPLING; CELL FREE SYSTEM; DENMARK; DNA EXTRACTION; ENVIRONMENTAL TEMPERATURE; FEMALE; FETUS; GENETIC ANALYSIS; GESTATIONAL AGE; HUMAN; HUMAN CELL; NON INVASIVE MEASUREMENT; POLYMERASE CHAIN REACTION; PRENATAL CARE; PRENATAL SCREENING; SENSITIVITY ANALYSIS; TEMPERATURE MEASUREMENT;

BLOOD SPECIMEN COLLECTION; DNA; FEMALE; FETUS; GESTATIONAL AGE; HUMANS; POLYMERASE CHAIN REACTION; PREGNANCY; PRENATAL DIAGNOSIS; REPRODUCIBILITY OF RESULTS; RH-HR BLOOD-GROUP SYSTEM; TEMPERATURE; TIME FACTORS; TRANSPORTATION;

EID: 84885803374     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076990     Document Type: Article

References (47)

1. Daniels G, Finning K, Martin P, (2010) Noninvasive Fetal Blood Grouping: Present and Future. Clin Lab Med 30: 431-442.
2. Lo YMD, Chiu RWK, (2012) Genomic Analysis of Fetal Nucleic Acids in Maternal Blood. Annu Rev Genomics Hum Genet 13: 285-306.
3. Bianchi DW, (2012) From prenatal genomic diagnosis to fetal personalized medicine: progress and challenges. Nature Medicine 18: 1041-51.
4. Simpson JL, (2013) Cell-free fetal DNA and maternal serum analytes for monitoring embryonic and fetal status. Fertil Steril 99: 1124-34.
5. Hui L, Bianchi DW, (2013) Recent advances in the prenatal interrogation of the human fetal genome. Trends Genet 29: 84-91.
6. Scheffer PG, van der Schoot CE, Page-Christians GCML, de Haas M, (2011) Noninvasive fetal blood group genotyping of rhesus D, c, E and K in alloimmunised pregnant women: evaluation of a 7-year clinical experience. BJOG 118: 1340-8.
7. Hill M, Finning K, Martin P, Hogg J, Meaney C, et al. (2011) Non-invasive prenatal determination of fetal sex: translating research into clinical practice. Clin Genet 80: 68-75.
8. Hill M, Barrett AN, White H, Chitty LS, (2012) Uses of cell free fetal DNA in maternal circulation. Best Pract Res Clin Obstet Gynaecol 26: 639-54.
9. Urbaniak SJ, Greiss MA, (2000) RhD haemolytic disease of the fetus and the newborn. Blood Rev 14: 44-61.
10. Lo YMD, Corbetta N, Chamberlain PF, Rai V, Sargent IL, et al. (1997) Presence of fetal DNA in maternal plasma and serum. The Lancet 350: 485-487.
11. Faas BHW, Beuling EA, Christiaens GCML, von dem Borne AEG, van der Schoot CE, (1998) Detection of fetal RHD-specific sequences in maternal plasma. The Lancet 352: 1196.
12. Lo YMD, Hjelm NM, Fidler C, Sargent IL, Murphy MF, et al. (1998) Prenatal Diagnosis of Fetal RhD Status by Molecular Analysis of Maternal Plasma. N Engl J Med 339: 1734-1738.
13. Finning KM, Martin PG, Soothill PW, Avent ND, (2002) Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service. Transfusion 42: 1079-1085.
14. Finning K, Martin P, Daniels G, (2004) A Clinical Service in the UK to Predict Fetal Rh (Rhesus) D Blood Group Using Free Fetal DNA in Maternal Plasma. Ann N Y Acad Sci 1022: 119-123.
15. van der Schoot CE, Soussan AA, Koelewijn J, Bonsel G, Paget-Christiaens LGC, et al. (2006) Non-invasive antenatal RHD typing. Le génotypage RHD prénatal non invasif. Transfus Clin Biol 13: 53-57.
16. Finning K, Martin P, Summers J, Massey E, Poole G, et al. (2008) Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study. BMJ 336: 816-818.
17. Müller SP, Bartels I, Stein W, Emons G, Gutensohn K, et al. (2008) The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible. Transfusion 48: 2292-301.
18. Clausen FB, Christiansen M, Steffensen R, Jørgensen S, Nielsen C, et al. (2012) Report of the first nationally implemented clinical routine screening for fetal RHD in RhD negative women to ascertain the requirement for antenatal RhD prophylaxis. Transfusion 52: 752-8.
19. de Haas M, van der Ploeg CPB, Scheffer PG, Verlinden DA, Hirschberg H, et al. (2012) A nation-wide fetal RHD screening programme for targeted antenatal and postnatal anti-D. ISBT Science Series 7: 164-167.
20. Wikman AT, Tiblad E, Karlsson A, Olsson ML, Westgren M, et al. (2012) Noninvasive single-exon fetal RHD determination in a routine screening program in early pregnancy. Obstet Gynecol 120: 227-34.
21. Lo YMD, Tein MSC, Lau TK, Haines CJ, Leung TN, et al. (1998) Quantitative Analysis of Fetal DNA in Maternal Plasma and Serum: Implications for Noninvasive Prenatal Diagnosis. Am J Hum Genet 62: 768-775.
22. Zhang J, Fidler C, Murphy MF, Chamberlain PF, Sargent IL, et al. (2000) Determination of Fetal RhD Status by Maternal Plasma DNA Analysis. Ann N Y Acad Sci 906: 153-5.
23. Randen I, Hauge R, Kjeldsen-Kragh J, Fagerhol MK, (2003) Prenatal genotyping of RHD and SRY using maternal blood. Vox Sang 85: 300-306.
24. Rijnders RJP, van der Luijt RB, Peters EDJ, Goeree JK, van der Schoot CE, et al. (2003) Earliest gestational age for fetal sexing in cell-free maternal plasma. Prenat Diagn 23: 1042-1044.
25. Birch L, English CA, O'Donoghue K, Barigye O, Fisk NM, et al. (2005) Accurate and Robust Quantification of Circulating Fetal and Total DNA in Maternal Plasma from 5 to 41 Weeks of Gestation. Clin Chem 51: 312-320.
26. Akolekar R, Finning K, Kuppusamy R, Daniels G, Nicolaides KH, (2011) Fetal RHD genotyping in maternal plasma at 11-13 weeks of gestation. Fetal Diagn Ther 29: 301-6.
27. Chitty LS, Finning K, Massey E, Soothill P, Daniels G, (2011) Antenatal determination of fetal rhesus (Rh) D status using cell free fetal DNA in the maternal circulation before 20 weeks' gestation: Is routine application practical and beneficial? Arch Dis Child Fetal Neonatal Ed 96 (Suppl 1):: Fa1-Fa16.
28. Johnson KL, Dukes KA, Vidaver J, LeShane ES, Ramirez I, et al. (2004) Interlaboratory comparison of fetal male DNA detection from common maternal plasma samples by real-time PCR. Clin Chem 50: 516-521.
29. Galbiati S, Smid M, Gambini D, Ferrari A, Restagno G, et al. (2005) Fetal DNA detection in maternal plasma throughout gestation. Hum Genet 117: 243-248.
30. Müller SP, Bartels I, Stein W, Emons G, Gutensohn K, et al. (2011) Cell-free fetal DNA in specimen from pregnant women is stable up to 5 days. Prenat Diagn 31: 1300-4.
31. Barret AN, Zimmermann BG, Wang D, Holloway A, Chitty LS, (2011) Implementing Prenatal Diagnosis Based on Cell-Free Fetal DNA: Accurate Identification of Factors Affecting Fetal DNA Yield. PLoS ONE 6 (10):: 1-8.
32. Jorgez CJ, Dang DD, Simpson JL, Lewis DE, Bischoff FZ, (2006) Quantity versus quality: Optimal methods for cell-free DNA isolation from plasma of pregnant women. Genet Med 8: 615-619.
33. Clausen FB, Krog GR, Rieneck K, Dziegiel MH, (2007) Improvement in fetal DNA extraction from maternal plasma. Evaluation of the NucliSens Magnetic Extraction system and the QIAamp DSP Virus Kit in comparison with the QIAamp DNA Blood Mini Kit. Prenat Diagn 27: 6-10.
34. Legler TJ, Liu Z, Mavrou A, Finning K, Hromadnikova I, et al. (2007) Workshop report on the extraction of foetal DNA from maternal plasma. Prenat Diagn 27: 824-9.
35. Repiská G, Sedláèkova T, Szemes T, Celec P, Minárik G, (2012) Selection of the optimal manual method of cell free fetal DNA isolation from maternal plasma. Clin Chem Lab Med 8: 1-5.
36. Clausen FB, Krog GR, Rieneck K, Råsmark EEF, Dziegiel MH, (2011) Evaluation of Two Real-Time Multiplex PCR Screening Assays Detecting Fetal RHD in Plasma from RhD Negative Women to Ascertain the Requirement for Antenatal RhD Prophylaxis. Fetal Diagn Ther 29: 155-63.
37. Metcalfe P, Rigsby P, Tait E, Urbaniak S, (2012) An international reference reagent for the detection of RHD and SRY DNA in plasma. Vox Sang 102: 243-9.
38. Clausen FB, Krog GR, Rieneck K, Nielsen LK, Lundquist R, et al. (2005) Reliable test for prenatal prediction of fetal RhD type using maternal plasma from RhD negative women. Prenat Diagn 25: 1040-1044.
39. Jakobsen TR, Clausen FB, Rode L, Dziegiel MH, Tabor A, (2012) High levels of fetal DNA are associated with increased risk of spontaneous preterm delivery. Prenat Diagn 32: 840-5.
40. Angert RM, LeShane ES, Lo YMD, Chan LYS, Delli-Bovi LC, et al. (2003) Fetal Cell-free Plasma DNA Concentrations in Maternal Blood Are Stable 24 Hours after Collection: Analysis of First- and Third-Trimester Samples. Clin Chem 49: 195-198.
41. Zhang Y, Li Q, Hui N, Fei M, Hu Z, et al. (2008) Effect of formaldehyde treatment on the recovery of cell-free fetal DNA from maternal plasma at different processing times. Clin Chim Acta 397: 60-64.
42. Fernando MR, Chen K, Norton S, Krzyzanowski G, Bourne D, et al. (2010) A new methodology to preserve the original proportion and integrity of cell-free fetal DNA in maternal plasma during sample processing and storage. Prenat Diagn 30: 418-24.
43. Rieneck K, Bak M, Jønson L, Clausen FB, Krog GR, et al. (2013) Next-generation sequencing: proof of concept for antenatal prediction of the fetal Kell blood group phenotype from cell-free fetal DNA in maternal plasma. Transfusion DOI:10.1111/trf.12172.
44. Horinek A, Korabecna M, Panczak A, Gallova ZU, Nouzova K, et al. (2008) Cell-Free Fetal DNA in Maternal Plasma during Physiological Single Male Pregnancies: Methodology Issues and Kinetics. Fetal Diagn Ther 24: 15-21.
45. Jakobsen TR, Clausen FB, Rode L, Dziegiel MH, Tabor A, (2013) Identifying mild and severe preeclampsia in asymptomatic pregnant women by levels of cell-free fetal DNA. Transfusion DOI:10.1111/trf.12073.
46. Damkjaer MB, Perslev A, Clausen FB, Dziegiel MH, Jørgensen FS, (2012) Study of compliance with a new, targeted antenatal D immunization prevention programme in Denmark. Vox Sang 103: 145-9.
47. Daniels G, (2013) Variants of RhD- current testing and clinical consequences. Br J Haematol 161: 461-70.